GlySens Incorporated Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • GlySens Incorporated's estimated annual revenue is currently $420k per year.(i)
  • GlySens Incorporated's estimated revenue per employee is $70,000

Employee Data

  • GlySens Incorporated has 6 Employees.(i)
  • GlySens Incorporated grew their employee count by -40% last year.

GlySens Incorporated's People

NameTitleEmail/Phone
1
VP Clinical AffairsReveal Email/Phone
2
VP Regulatory Affairs and Quality AssuranceReveal Email/Phone
3
Sr. Director, Biosensor EngineeringReveal Email/Phone
4
Director Biosensor DevelopmentReveal Email/Phone
5
Development Engineering ManagerReveal Email/Phone
6
Principal Engineer, Data Analysis and AlgorithmsReveal Email/Phone
7
Senior Quality Assurance Engineer / SpecialistReveal Email/Phone
8
Manufacturing Supply Chain SpecialistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$212.8M10635%$65MN/A
#2
$35.6M2316%N/AN/A
#3
$45M299-4%$102.6MN/A
#4
$3.2M30-25%$21.3MN/A
#5
$34M2260%$42.9MN/A
#6
$3.6M34-28%$35MN/A
#7
$0.8M10N/AN/AN/A
#8
$12.6M90-9%N/AN/A
#9
$17.4M1240%$96.4MN/A
#10
$5.2M49-25%$75.6MN/A
Add Company

What Is GlySens Incorporated?

At GlySens®, we are dedicated to advancing the care of individuals with diabetes through the development of a long term, implantable continuous glucose monitoring technology. Since the company's inception in 1998, we have focused on designing and developing the world's first truly long term, wireless, implantable, continuous glucose monitor, the Eclipse® ICGM® System. Our goal is to empower individuals with easy, at-a-glance, worry-free diabetes technologies that seamlessly deliver the information they need to optimize care, while freeing them to live life on their own terms. CAUTION – Investigational Device. Limited by Federal law to investigational use.

keywords:N/A

N/A

Total Funding

6

Number of Employees

$420k

Revenue (est)

-40%

Employee Growth %

N/A

Valuation

N/A

Accelerator

GlySens Incorporated News

2022-04-20 - Diabetes Care Devices Market Analysis and Research Report ...

Echo Therapeutics, Inc. Glysens Incorporated. The global diabetes care devices market was valued at $6,867 million in 2016, and is growing at a...

2022-04-17 - Global Continuous Non-invasive Glucose Monitoring System ...

Dexcom; Abbott Laboratories; Medtronic; Senseonics Holdings; GlySens Incorporated; Meiqi Medical Equipment; San Meditech.

2022-04-17 - Continuous Glucose Monitoring Sales Market Size, Outlook ...

... Outlook And Forecast | Dexcom, Abbott Laboratories, Medtronic, Senseonics Holdings, GlySens Incorporated, Roche, Terumo, POCTech.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.7M6-25%N/A
#2
$0.4M6N/AN/A
#3
$0.4M6N/AN/A
#4
$0.4M6N/AN/A
#5
$0.4M6N/AN/A